FREDUN · Ratios · TradingHolo

Markets › India › NSE › FREDUN

Fredun Pharmaceuticals Ltd.

NSE:FREDUNHealth Technology

₹1,438.40−2.66%At closeAt close · Mon 19 Oct · ≈ AED 55.50 · Market cap $256.63M

🔔 Alert▶ Test a strategy

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Trend	YoY
Gross margin	12.0%	11.5%	15.2%	16.5%	17.6%	20.2%		+2.6 pts
Operating margin	5.5%	5.3%	9.2%	9.9%	10.7%	13.1%		+2.4 pts
Net margin	1.5%	2.9%	4.0%	4.5%	4.3%	5.1%		+0.8 pts
EBITDA margin	7.0%	6.2%	10.2%	11.0%	11.8%	14.4%		+2.5 pts
Return on equity	4.7%	9.3%	11.2%	12.9%	14.0%	11.7%		−2.2 pts
Return on assets	1.2%	3.4%	4.2%	5.1%	4.0%	5.1%		+1.0 pts
Return on capital employed	9.8%	10.4%	16.7%	24.4%	30.5%	24.1%		−6.5 pts
Debt / equity	0.9×	0.8×	0.9×	0.9×	1.2×	0.9×		−26.9%
Debt / assets	24.5%	28.2%	33.6%	34.3%	34.5%	37.7%		+3.2 pts
Interest coverage	1.8×	2.5×	2.7×	2.5×	2.2×	2.1×		−2.7%
Current ratio	1.5×	2.1×	2.0×	1.5×	1.3×	1.7×		+28.9%
Quick ratio	0.7×	1.4×	0.6×	0.5×	0.6×	0.6×		+3.2%
Cash ratio	0.0×	0.0×	0.0×	0.0×	0.0×	0.2×		+10350.9%
Asset turnover	0.8×	1.2×	1.1×	1.1×	0.9×	1.0×		+6.3%
Inventory turnover	1.7×	4.2×	1.5×	1.6×	1.6×	1.6×		+0.8%
Receivables turnover	3.2×	2.5×	7.9×	5.3×	2.6×	6.8×		+165.8%
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%		—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ